Works matching IS 2160763X AND DT 2016 AND VI 5 AND IP 1

Results: 10

Population pharmacokinetic modeling and noncompartmental analysis demonstrated bioequivalence between metformin component of metformin/vildagliptin fixed-dose combination products and metformin immediate-release tablet sourced from various countries.

Published in:

Clinical Pharmacology in Drug Development, 2016, v. 5, n. 1, p. 40, doi. 10.1002/cpdd.191

By:

Chitnis, Shripad D.;
Han, Yi;
Yamaguchi, Masayuki;
Mita, Sachiko;
Zhao, Rong;
Sunkara, Gangadhar;
Kulmatycki, Kenneth

Publication type:

Article

The Passing of David A. Flockhart, M.D., Ph.D.

Published in:: 2016
Publication type:: Editorial

Issue Information.

Published in:: 2016
Publication type:: Editorial

Relative bioavailability of diclofenac potassium from softgel capsule versus powder for oral solution and immediate-release tablet formulation.

Published in:

Clinical Pharmacology in Drug Development, 2016, v. 5, n. 1, p. 76, doi. 10.1002/cpdd.215

By:

Bende, Girish;
Biswal, Shibadas;
Bhad, Prafulla;
Chen, Yuming;
Salunke, Atish;
Winter, Serge;
Wagner, Robert;
Sunkara, Gangadhar

Publication type:

Article

Safety, pharmacokinetics, and pharmacodynamics of PD 0348292, an oral, direct factor Xa inhibitor, after single and multiple dosings in healthy subjects.

Published in:

Clinical Pharmacology in Drug Development, 2016, v. 5, n. 1, p. 13, doi. 10.1002/cpdd.232

By:

Xuan, Dawei;
McBride, Scott;
Wastall, Philip;
Porcari, Anthony;
DiCarlo, Lorenzo;
Boyd, Rebecca A.

Publication type:

Article

Bioequivalence and comparative pharmacodynamics of insulin lispro 200 U/mL relative to insulin lispro (Humalog®) 100 U/mL.

Published in:

Clinical Pharmacology in Drug Development, 2016, v. 5, n. 1, p. 69, doi. 10.1002/cpdd.221

By:

de la Peña, Amparo;
Seger, Mary;
Soon, Danny;
Scott, Adam J.;
Reddy, Shobha R.;
Dobbins, Michael A.;
Brown‐Augsburger, Patricia;
Linnebjerg, Helle

Publication type:

Article

Essential criteria for pharmacokinetic studies supporting bioequivalence of inhaled tiotropium bromide products.

Published in:

Clinical Pharmacology in Drug Development, 2016, v. 5, n. 1, p. 52, doi. 10.1002/cpdd.187

By:

Sharma, Ashish;
Weber, Benjamin;
Wein, Martina;
Hallmann, Christoph;
Meibohm, Bernd

Publication type:

Article

Tolerability, safety, and pharmacokinetics of the novel cathepsin A inhibitor SAR164653 in healthy subjects.

Published in:

Clinical Pharmacology in Drug Development, 2016, v. 5, n. 1, p. 57, doi. 10.1002/cpdd.201

By:

Tillner, Joachim;
Lehmann, Anne;
Paehler, Tobias;
Lukacs, Zoltan;
Ruf, Sven;
Sadowski, Thorsten;
Pinquier, Jean‐Louis;
Ruetten, Hartmut

Publication type:

Article

Perspectives in Drug Development and Clinical Pharmacology: The Discovery of Histamine H<sub>1</sub> and H<sub>2</sub> Antagonists.

Published in:

Clinical Pharmacology in Drug Development, 2016, v. 5, n. 1, p. 5, doi. 10.1002/cpdd.236

By:

Jones, Alan Wayne

Publication type:

Article

Pharmacokinetic drug-drug interaction assessment of LCZ696 (an angiotensin receptor neprilysin inhibitor) with omeprazole, metformin or levonorgestrel-ethinyl estradiol in healthy subjects.

Published in:

Clinical Pharmacology in Drug Development, 2016, v. 5, n. 1, p. 27, doi. 10.1002/cpdd.181

By:

Gan, Lu;
Jiang, Xuemin;
Mendonza, Anisha;
Swan, Therese;
Reynolds, Christine;
Nguyen, Joanne;
Pal, Parasar;
Neelakantham, Srikanth;
Dahlke, Marion;
Langenickel, Thomas;
Rajman, Iris;
Akahori, Mizuki;
Zhou, Wei;
Rebello, Sam;
Sunkara, Gangadhar

Publication type:

Article